JPRN-UMIN000012659已完成未知
Stentless mitral valve replacement using autologous pericardium study - Stentless mitral valve replacement using autologous pericardium study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Active malignancy except for in situ cancer 2. Dialysis 3. Participating in other trials 4. Myocardial infarction in the last 6 months 5. Stroke in the last 6 months 6. Previous percutaneous coronary stenting in a month before surgery 7. Concomitant procedures other than tricuspid valve repair, maze operation and pulmonary vein isolation. 8. Severe left ventricular dysfunction (ejection fraction less than 0.30) 9. When excellent outcomes and prognosis are expected with standard prosthetic mitral valve replacement 10. When a principal investigator deems a patient inappropriate as a trial subject
研究者
相似试验
已完成
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral valve diseaseJPRN-UMIN000021445Keio University School of Medicine30
暂停
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral regurgitationJPRN-jRCT1032180087Shimokawa Tomoki25
已完成
不适用
Mitral valve surgery using stentress bioprosthesis made from autologous pericardiumMitral insufficiencyJPRN-UMIN000017201CV suregry5
暂停
不适用
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)Moderate-to-severe or severe symptomatic mitral regurgitationJPRN-UMIN000038202Medtronic Japan Co., Ltd1,350
招募中
不适用
Transcatheter Mitral Valve Replacement with the Medtronic Intrepid* TMVR Transfemoral System in patients with severe symptomatic mitral regurgitation - APOLLO-EU Trialleaking heart valve10046973mitral regurgitationNL-OMON56063Medtronic B.V.24